Value Analysis Is Under Pressure. Patients Will Feel It First.

Healthcare does not suffer from a lack of frameworks. What it suffers from is fragmentation of responsibility.

Value analysis was never meant to be just a committee, a meeting, or a checkpoint in the supply chain process. It was meant to be a discipline. One that brings clinicians, supply chain leaders, finance, IT, and frontline caregivers together around a single purpose: delivering the safest, highest value care possible for patients. Today, that discipline is under real strain.

Hospitals are operating in an environment where financial pressure is constant, margins remain fragile, and the expectation to do more with less has become the norm. At the same time, supply chains are more complex than they have ever been. Vendor ecosystems are larger. Technology dependencies are deeper. And the risks tied to third-party access are more serious than many organizations are prepared to acknowledge.

What has changed is not the intent of value analysis. What has changed is the context in which it must operate.

A Discipline Under Increasing Demands

In recent years, healthcare leaders have been forced to juggle rising labor costs, supply expense volatility, and expanding digital footprints. Cybersecurity incidents tied to third-party vendors are no longer rare or hypothetical. They are happening in real time, and the downstream effects touch patient care, clinical operations, and staff trust.

Yet value analysis is still too often treated as someone else’s responsibility: supply chain is asked to drive savings, clinicians are asked to protect outcomes, IT is asked to manage cyber risk, and OR nurses are asked to adapt, again and again.

And the value analysis manager is expected to reconcile all of it. That is not sustainable.

Collaboration has always been the foundation of effective value analysis. But collaboration does not happen by accident. It has to be intentionally designed, reinforced by leadership, and protected when pressure mounts. Without that shared commitment, value analysis becomes transactional instead of transformational.

- Karen Niven, President of Association of Healthcare Value Analysis Professionals (AHVAP) from 2024-2025

Where the Fracture Happens

Across health systems, a familiar pattern emerges. Decisions are made with partial information. Frontline perspectives arrive late in the process. Vendor access is governed inconsistently. And the people closest to patient care are left to absorb the consequences.

This is not a failure of effort. It is a failure of alignment. When value analysis is isolated within supply chain, it loses clinical credibility. When clinicians are invited only at the end, trust erodes. When vendor access is loosely governed, patient safety is put at risk. None of this happens because people do not care. It happens because the work has become fragmented.

Healthcare leaders themselves acknowledge this tension. Industry conversations increasingly reflect a sense that systems are stretched thin, governance is uneven, and resilience depends on tighter coordination across roles that have historically operated in silos. Value analysis sits directly in the middle of that reality.

The Front Line Holds the Truth

The operating room is where policy meets practice, and not everything survives the transition. OR nurses, procedural staff, and clinical leaders are the final stewards of value. They see which products perform. They experience which vendors add clarity and support, and which introduce disruption. They feel the impact of rushed evaluations, poorly communicated changes, and inconsistent standards.

When these voices are excluded, value analysis becomes theoretical. When they are engaged early and consistently, it becomes credible. Karen Niven has long emphasized that value analysis only works when it reflects the lived reality of care delivery. That truth has not changed. What has changed is how costly it has become to ignore it.

Organizations that invest in cross functional governance and quality infrastructure consistently show stronger outcomes, both clinically and financially. The connection is not accidental. Alignment creates trust. Trust enables better decisions. Better decisions protect patients and staff alike.

Vendors Are Not Outsiders to This Work

Vendors also carry responsibility here. When value analysis works well, vendors are not transactional sales agents moving from account to account. They are informed, accountable partners who understand clinical realities, respect governance, and contribute meaningfully to patient safety and operational consistency. The most effective vendor relationships are built on transparency, preparedness, and trust. That means showing up educated on the health system’s standards, credentialed appropriately, aligned to clinical priorities, and willing to support long-term outcomes rather than short-term wins. When vendors engage as partners, they strengthen value analysis. When they bypass it, pressure it, or treat it as a hurdle to clear, they weaken the very system they depend on. In today’s environment, partnership is not optional. It is part of the obligation to care.

A Shared Responsibility, Not a Department

Value analysis cannot succeed if it is treated as a supply chain function alone.
It cannot mature if clinicians are expected to endorse decisions they did not help shape.
It cannot protect patients if vendor access is unmanaged or inconsistently enforced.
And it cannot endure if frontline teams are asked to comply without understanding the “why”.

This is a collective responsibility. As the former president of AHVAP has been clear about this throughout her career, value analysis is a team effort. It depends on leadership support, clinical partnership, operational discipline, and frontline trust. When any one of those breaks down, the entire model weakens. 

Today, the stakes are simply higher. A single vendor credential can become a cyber vulnerability. A single product decision can ripple across dozens of facilities. A single misalignment can undermine months of careful work. A misinformed procurement decision can have a ripple effect across patient outcomes. 

A Call for Alignment

This is not a call for new frameworks or more meetings. It is a call for shared ownership.

The future of value analysis belongs to organizations willing to treat it not as a process, but as a promise. A promise that the right products will be evaluated thoughtfully. That the right partners will be held to consistent standards. And that the people delivering care will be respected as essential voices in the process.

Value analysis is not broken. But without collective commitment, it is at risk. And the cost of getting it wrong is one healthcare can no longer afford.